跳至主要内容
临床试验/ACTRN12618001181291
ACTRN12618001181291已完成1 期

The effects of AD047 and AD282 on obstructive sleep apnoea (OSA)

Apnimed0 个研究点目标入组 11 人开始时间: 2018年7月17日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Otherwise healthy men and women with obstructive sleep apnoea aged 18 years or older.

排除标准

  • Exclusion Criteria:
  • Any chronic medical condition other than well controlled hypertension, hyperlipidemia, diabetes.
  • Any medication known to influence breathing, sleep/arousal or muscle physiology.
  • Claustrophobia.
  • Inability to sleep supine.
  • Known allergy to study medications
  • Benign prostatic hyperplasia or urinary retention
  • Individuals with underlying cardiac disease, such as arrhythmias.
  • Individuals taking psychiatric medications, such as tricyclic antidepressants, or any of the studied medications for medical care.
  • History of moderate or severe hepatic or renal impairment.
  • History of seizures.
  • For women: Pregnancy.

研究者

发起方
Apnimed

相似试验

The effects of AD047 and AD282 on obstructive sleep... | 临床试验